A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1-7 (TXA-127) for the treatment of severe COVID-19.

Saved in:
Bibliographic Details
Title: A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1-7 (TXA-127) for the treatment of severe COVID-19.
Authors: Wagener G; Department of Anesthesiology, Columbia University Irving Medical Center, 622 West 168th Street, PH 5, New York, NY, 10032, USA., Goldklang MP; Department of Anesthesiology, Columbia University Irving Medical Center, 622 West 168th Street, PH 5, New York, NY, 10032, USA., Gerber A; Department of Anesthesiology, Columbia University Irving Medical Center, 622 West 168th Street, PH 5, New York, NY, 10032, USA., Elisman K; Department of Anesthesiology, Columbia University Irving Medical Center, 622 West 168th Street, PH 5, New York, NY, 10032, USA., Eiseman KA; Department of Anesthesiology, Columbia University Irving Medical Center, 622 West 168th Street, PH 5, New York, NY, 10032, USA.; Columbia University Vagelos College of Physicians and Surgeons, New York-Prebysterian Columbia University Medical Center, 630 West 168th Street, New York, NY, 10032, USA., Fonseca LD; Department of Anesthesiology, Columbia University Irving Medical Center, 622 West 168th Street, PH 5, New York, NY, 10032, USA., D'Armiento JM; Department of Anesthesiology, Columbia University Irving Medical Center, 622 West 168th Street, PH 5, New York, NY, 10032, USA. jmd12@cumc.columbia.edu.
Source: Critical care (London, England) [Crit Care] 2022 Jul 28; Vol. 26 (1), pp. 229. Date of Electronic Publication: 2022 Jul 28.
Publication Type: Letter; Randomized Controlled Trial
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9801902 Publication Model: Electronic Cited Medium: Internet ISSN: 1466-609X (Electronic) Linking ISSN: 13648535 NLM ISO Abbreviation: Crit Care Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first